Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports .
Best for: Concentrated exposure to the 25 largest, most liquid biotech stocks . Strategy: Focuses on profitable blue-chip biotechs . Expense Ratio: 0.35% . best biotech etf to buy now
Best for: Speculative bets on high-frontier tech like gene editing and CRISPR . Strategy: Actively managed by Cathie Wood's team, targeting
7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money Best for: Concentrated exposure to the 25 largest,
Your (e.g., comfortable with high volatility)? Your investment timeframe ?
AI responses may include mistakes. For financial advice, consult a professional. Learn more
Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure .